FDA Warning Letter — American Preclinical Services
The FDA took a Warning Letter action against American Preclinical Services on Feb 12, 2019 (Minneapolis, MN). The action was issued by CDRH and concerns devices products.
Action Details
- Facility
- American Preclinical Services
- Date
- Feb 12, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Center
- CDRH
- Location
- Minneapolis, MN (United States)